TrialLancet (London, England)2018

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.

Nikola Sprigg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.